Analysis of data from the CDC/FDA Vaccine Adverse Event Reporting System (1990-2009) on Guillain-Barre syndrome after hepatitis vaccination in the USA

被引：7

作者：

Souayah, Nizar ^{[1
]}

Yacoub, Hussam A. ^{[1
]}

Khan, Hafiz M. R. ^{[2
]}

Farhad, Khosro ^{[1
]}

Maybodi, Leila ^{[1
]}

Qureshi, Adnan I. ^{[3
]}

Menkes, Daniel L. ^{[4
]}

机构：

[1] Univ Med & Dent New Jersey, Dept Neurol, Newark, NJ 07103 USA

[2] Florida Int Univ, Dept Biostat, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA

[3] Univ Minnesota, Zeenat Qureshi Stroke Res Ctr, Minneapolis, MN USA

[4] Univ Connecticut, Ctr Hlth, Dept Neurol, Farmington, CT USA

来源：

JOURNAL OF CLINICAL NEUROSCIENCE | 2012年 / 19卷 / 08期

关键词：

Adverse effect; CDC; Guillain-Barre syndrome; Hepatitis vaccine; Vaccination; VAERS; UNITED-STATES; INFLUENZA VACCINATION; B VACCINATION; ASSOCIATION; PREVENTION;

D O I：

10.1016/j.jocn.2011.11.022

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

We used data from the Vaccine Adverse Event Reporting System, supplemented by additional data provided by the Center for Biologics Evaluation and Research, to identify 189 patients with Guillain-Barre syndrome (GBS) reported after hepatitis vaccination with a mean age of 30.65 years, affecting men and women equally. Among vaccinated patients, 133 (70%) developed GBS within six weeks, 30(15.9%) after six weeks, and for the remaining 26 (13.7%), the time between GBS occurrence and vaccination was not specified. The reporting rate of post-hepatitis vaccine GBS is approximately 3.4 cases per one million vaccinations, which is in the range expected in the general population. The unbalanced distribution of reports in the first six weeks after vaccination suggests that some cases of GBS may be triggered by vaccination. Nonetheless, the low incidence of hepatitis vaccine-associated GBS, and the dramatic incidence reduction of hepatitis and its complications after vaccination, support the current guidelines for vaccination. (C) 2012 Published by Elsevier Ltd.

引用

页码：1089 / 1092

页数：4

共 50 条

[31] Encephalitis after Vaccination in United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. [1990-2010]
Al Qudah, Zaid
Abukwaik, Wael
Patel, Hemali
Souayah, Nizar
NEUROLOGY, 2012, 78
[32] Stroke after Vaccination in United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. [1990-2010]
Al Qudah, Zaid
Abukwaik, Wael
Souayah, Nizar
NEUROLOGY, 2012, 78
[33] PEDIATRIC MYASTHENIA GRAVIS AFTER VACCINATION IN THE UNITED STATES: A REPORT FROM THE CDC/FDA VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2017)
Sanghani, Nirav
Hanumanthu, Rajanigandhi
Shah, Shreya
Souayah, Nizar
MUSCLE & NERVE, 2018, 58 : S100 - S100
[34] Guillian-Barre Syndrome after Influenza Vaccination in the United States, 1999-2015. A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study
Veitia, Jesyree
Gomez, Francisco
Nsar, Abu
Souayah, Nizar
NEUROLOGY, 2016, 86
[35] Development of Clinically Isolated Syndrome after Vaccination, A CDC/FDA Vaccine Adverse Event Reporting System (VAERS) Study, [1985-2017]
Eddin, Moamina Fakher
Patel, Janaki
Alchaki, Abdul Rahman
Souayah, Nizar
NEUROLOGY, 2018, 90
[36] Miller Fischer Syndrome after Vaccination in the United States: A CDC/FDA Vaccine Adverse Event Reporting System Study, 1999-2017
Hilmi, Kazi Md Asif
Souayah, Nizer
Nolasco, Kevin
Tamanna, Kazi Nusrat
NEUROLOGY, 2019, 92 (15)
[37] Pediatric Myasthenia Gravis After Vaccination in the United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System. (1990-2017)
Hanumanthu, Rajanigandhi
Sanghani, Nirav
Shah, Shreya
Souayah, Nizar
NEUROLOGY, 2018, 90
[38] The contribution of the Vaccine adverse event Text Mining system to the classification of possible Guillain-Barre Syndrome reports
Botsis, T.
Woo, E. J.
Ball, R.
APPLIED CLINICAL INFORMATICS, 2013, 4 (01): : 88 - 99
[39] Amyotrophic Lateral Sclerosis after Vaccine in United States. A Report from the CDC/FDA Vaccine Adverse Event Reporting System (1990-2010)
Tishuk, Pavel
Ji, Andrew B.
Farhad, Khosro
Khan, Hafiz
NEUROLOGY, 2011, 76 (09) : A517 - A517
[40] Adverse Event Reporting Patterns of Newly Approved Drugs in the USA in 2006: An Analysis of FDA Adverse Event Reporting System Data
Pankdeep Chhabra
Xing Chen
Sheila R. Weiss
Drug Safety, 2013, 36 : 1117 - 1123

← 1 2 3 4 5 →